Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2006
[Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient]Tadashi Osaki, Takayuki Takimoto, Mitsugi Furukawa, et al.
Neoplasia (New York, N.Y.)|October 13, 2006
Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivationYoshitaka Ogata, Tadashi Osaki, Tetsuji Naka, et al.
Cancer Research|October 5, 2006
Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cellsYoshiyuki Saito, Isao Tachibana, Yoshito Takeda, et al.
Cell Reports|November 4, 2015
Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B CellsJianbo Sun, Jiguang Wang, Evangelos Pefanis, et al.
The European Respiratory Journal|May 5, 2012
Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiologyAlice M Turner, Laura McGowan, Alan Millen, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2012
CXCL12 as a biological marker for the diagnosis of tuberculous pleurisySatoshi Kohmo, Takashi Kijima, Masahide Mori, et al.
International Journal of Clinical Practice|December 10, 2016
Improved quality of life in asthma patients under long-term therapy: Assessed by AHQ-JapanYuji Tohda, Takashi Iwanaga, Hiroyuki Sano, et al.
BMC Cancer|July 20, 2012
Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding studySeigo Minami, Takashi Kijima, Ryo Takahashi, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2012
Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancerTakayuki Shiroyama, Takashi Kijima, Kiyoshi Komuta, et al.
Cancer Science|August 22, 2013
Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cellsKazuki Shimada, Satoshi Serada, Minoru Fujimoto, et al.
Pageof 7